Geode Capital Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.3M | Buy |
|
|||||
|
2025
Q1 | $23.2M | Buy |
|
|||||
|
2024
Q4 | $31.8M | Buy |
|
|||||
|
2024
Q3 | $34M | Buy |
|
|||||
|
2024
Q2 | $18.4M | Buy |
|
|||||
|
2024
Q1 | $20.4M | Buy |
|
|||||
|
2023
Q4 | $21.7M | Buy |
|
|||||
|
2023
Q3 | $13.2M | Sell |
|
|||||
|
2023
Q2 | $20.5M | Buy |
|
|||||
|
2023
Q1 | $19.7M | Buy |
|
|||||
|
2022
Q4 | $20.8M | Buy |
|
|||||
|
2022
Q3 | $12.3M | Buy |
|
|||||
|
2022
Q2 | $5.2M | Buy |
|
|||||
|
2022
Q1 | $3.68M | Sell |
|
|||||
|
2021
Q4 | $3.99M | Buy |
|
|||||
|
2021
Q3 | $1.01M | Buy |
|
|||||
|
2021
Q2 | $700K | Buy |
|
|||||
|
2021
Q1 | $382K | Buy |
|
|||||
|
2020
Q4 | $257K | Sell |
|
|||||
|
2020
Q3 | $204K | Buy |
|
|||||
|
2020
Q2 | $195K | Buy |
|
|||||
|
2020
Q1 | $69K | Hold |
|
|||||
|
2019
Q4 | $74K | Hold |
|
|||||
|
2019
Q3 | $113K | Sell |
|
|||||
|
2019
Q2 | $319K | Sell |
|
|||||
|
2019
Q1 | $673K | Buy |
|
|||||
|
2018
Q4 | $697K | Buy |
|
|||||
|
2018
Q3 | $1.22M | Buy |
|
|||||
|
2018
Q2 | $1.34M | Buy |
|
|||||
|
2018
Q1 | $712K | Buy |
|
|||||
|
2017
Q4 | $964K | Buy |
|
|||||
|
2017
Q3 | $772K | Buy |
|
|||||
|
2017
Q2 | $398K | Buy |
|
|||||
|
2017
Q1 | $148K | Buy |
|